Innovation for Best RNA Drugs
Innovation for Best RNA Drugs
Innovation for Best RNA Drugs
Overview of siRNA
SiranBio was established in May 2022 in Suzhou Industrial Park. We are a biotech company specialized in siRNA drug development. Our core team is consisted of top scientists and pioneers of siRNA drugs in China. Several prestigious awards has been given to our company since its inception, such as The Leading Enterprise in Suzhou Industrial Park and as Gusu Leading Enterprise in 2022.
"
We have developed comprehensive and proprietary platform technologies which encompass the whole process of siRNA drug development, including siRNA sequence design and screening, chemical modifications for PD enhancement and off-target attenuation (eSAFE), liver and extrahepatic delivery (STORK), and dual-targeting siRNA. Based on these innovative technologies, we very quickly established a robust pipeline with potentials to become First-in-Class (FIC) and Best-in-Class (BIC) siRNA therapeutics for several important therapeutic areas, including anti-viral, cardiovascular and metabolic diseases, autoimmune diseases, CNS diseases.
We always put the patients’ needs in the highest priority, to innovate best siRNA drugs for the health and well-being of human kind.
LEARN MORE
Overview of siRNA
Small interfering RNAs (siRNAs) are short double-strand RNA molecues less than 30 nt long...
SiranBio's Drug Discovery Platforms
SiranBio developed comprehensive, cutting-edge and proprietary platform technologies for siRNA drug discovery...
News
【2024AASLD】First-in-class: Dual-Targeting siRNA for the Functional Cure of Chronic Hepatitis B, SiranBio’s SA1211 Achieved Superb Combo Treatment Results by a Single Molecule
[2024EASL]: Siran Bio Presents Core Data on Functional Cure of Anti-PD-L1 siRNA Pipeline SA012
Siran Bio Presents at CRT2024 Conference in the US - Sharing Research Findings on SA016, a New Antihypertensive siRNA Drug
Scan to follow us
Phone：0086-512-65295956
Email：info@siranbio.com
